causes of death in vertically infected paediatric hiv-seropositives- karnataka experience

1
POSTER PRESENTATION Open Access Causes of death in vertically infected paediatric HIV-seropositives- Karnataka experience Suresh Shastri * , Bharat Rewari, Pavithra Boregowda From 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) Marseille, France. 23-25 May 2012 Background Children represent a population at higher risk of HIV-1 infection and AIDS-related death. Tuberculosis is a common cause of severe lung disease and death in chil- dren infected with HIV, particularly those living in areas of high tuberculosis prevalence. We investigated the causes of death in HIV-infected paediatric patients. Methodology A retrospective survey conducted in 29 ART centres in Karnataka, India. Medical records of all deaths that occurred between January and September 2011 amongst paediatric patients were reviewed. Immediate and under- lying causes of death were described. Results Ninety-seven deaths occurred between January-Septem- ber 2011. 55% of the deceased were males. The mean duration of survival on antiretroviral therapy was 36 weeks. Median age at time of death was 10 years (range 1-19) median CD4 count was 210 cells/μl (7-2500); 57% had CD4 cell count <250 cells/μl. In all, 64 causes of death were reported. In 44% (28/64), the causes were WHO clinical stage IV AIDS-defining illness, 36% (23/ 64) and 2% (1/64) were stage III and stage II conditions, respectively. Adverse effects to anti retrovirals were noted in 6% (4/64) of patients. Multiple causes were also reported in 6% (4/64). Other immediate causes of death were cardio respiratory arrest (2), suicide (1) and intra-cerebral haemorrhage (1). Infections were noted in 22% (14/64) patients. 43% (23/64) patients had tubercu- losis at the time of death. Patients dying from AIDS- related events were more often men (17 out of 31). Conclusion Although antiretroviral therapy has substantially and dramatically decreased AIDS-related opportunistic infec- tions (OIs) and deaths, prevention and management of OIs remain critical components of care for HIV-infected children. Published: 25 May 2012 doi:10.1186/1742-4690-9-S1-P144 Cite this article as: Shastri et al.: Causes of death in vertically infected paediatric HIV-seropositives- Karnataka experience. Retrovirology 2012 9 (Suppl 1):P144. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] Karnataka State Aids Prevention Society, Bangalore, India Shastri et al. Retrovirology 2012, 9(Suppl 1):P144 http://www.retrovirology.com/content/9/S1/P144 © 2012 Shastri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: pavithra

Post on 30-Sep-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Causes of death in vertically infected paediatric HIV-seropositives- Karnataka experience

POSTER PRESENTATION Open Access

Causes of death in vertically infected paediatricHIV-seropositives- Karnataka experienceSuresh Shastri*, Bharat Rewari, Pavithra Boregowda

From 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID)Marseille, France. 23-25 May 2012

BackgroundChildren represent a population at higher risk of HIV-1infection and AIDS-related death. Tuberculosis is acommon cause of severe lung disease and death in chil-dren infected with HIV, particularly those living in areasof high tuberculosis prevalence. We investigated thecauses of death in HIV-infected paediatric patients.

MethodologyA retrospective survey conducted in 29 ART centres inKarnataka, India. Medical records of all deaths thatoccurred between January and September 2011 amongstpaediatric patients were reviewed. Immediate and under-lying causes of death were described.

ResultsNinety-seven deaths occurred between January-Septem-ber 2011. 55% of the deceased were males. The meanduration of survival on antiretroviral therapy was 36weeks. Median age at time of death was 10 years (range1-19) median CD4 count was 210 cells/μl (7-2500); 57%had CD4 cell count <250 cells/μl. In all, 64 causes ofdeath were reported. In 44% (28/64), the causes wereWHO clinical stage IV AIDS-defining illness, 36% (23/64) and 2% (1/64) were stage III and stage II conditions,respectively. Adverse effects to anti retrovirals werenoted in 6% (4/64) of patients. Multiple causes werealso reported in 6% (4/64). Other immediate causes ofdeath were cardio respiratory arrest (2), suicide (1) andintra-cerebral haemorrhage (1). Infections were noted in22% (14/64) patients. 43% (23/64) patients had tubercu-losis at the time of death. Patients dying from AIDS-related events were more often men (17 out of 31).

ConclusionAlthough antiretroviral therapy has substantially anddramatically decreased AIDS-related opportunistic infec-tions (OIs) and deaths, prevention and management ofOIs remain critical components of care for HIV-infectedchildren.

Published: 25 May 2012

doi:10.1186/1742-4690-9-S1-P144Cite this article as: Shastri et al.: Causes of death in vertically infectedpaediatric HIV-seropositives- Karnataka experience. Retrovirology 2012 9(Suppl 1):P144.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit* Correspondence: [email protected]

Karnataka State Aids Prevention Society, Bangalore, India

Shastri et al. Retrovirology 2012, 9(Suppl 1):P144http://www.retrovirology.com/content/9/S1/P144

© 2012 Shastri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.